Objectives This systematic review aimed to describe medication non-adherence among
people living with multimorbidity according to the current literature, and synthesise …

Objective: Opioid use disorder (OUD) in the United States has surged, with an estimated 2.5
million needing treatment. The aim of this article is to provide a clinical overview of the key …

Fentanyl and its analogues have played an increasing role in opioid overdose deaths
across the country over the past decade. Such high-potency, non-prescription opioids are …

Introduction Fentanyl is a potent synthetic opioid that has contributed to increasing overdose
deaths in the United States in recent years. Concern over safety and efficacy of agonist …

Introduction Illicitly manufactured fentanyl (IMF) is a potent synthetic opioid that has been
contributing to overdose deaths in the United States. This study examined intake toxicology …

Background Substance use disorder (SUD) is a major risk factor for homelessness, but the
specific association of opioid use disorder (OUD) and homelessness in the context of their …

Introduction Treatment retention is associated with better outcomes and reduced risk
amongst people experiencing opioid use disorder (OUD). Despite this, treatment retention …

Background Opioid overdose deaths have become a public health crisis in North America,
and those who are homeless are particularly vulnerable. Methadone maintenance treatment …

Abstract Introduction Following the March 2020 federal declaration of a COVID-19 public
health emergency, in line with recommendations for social distancing and decreased …

Objectives To describe 2 case reports in which high-dose administration of sublingual
buprenorphine/naloxone quickly stabilized fentanyl users who presented to the hospital. To …